As 2024 comes to a close, we reflect on the incredible contributions of nurses and clinicians across the United States and around the world who deliver compassionate care every day. Your dedication transforms patient outcomes, and we are honored to support your vital work. This year, the BioButton® wearable device has been trusted to monitor tens of thousands of patients each month, providing continuous, actionable insights that empower care teams and enhance patient safety across hospitals and homes. We are inspired by the stories of how this technology is making a difference—helping clinicians save lives, reduce workloads, and provide peace of mind to patients and their families. Looking ahead, we are so excited about what’s possible in 2025. Together, we will continue to advance continuous monitoring and clinical intelligence, working toward a future where every patient receives the proactive, personalized care they deserve. To all who have been part of this journey, thank you. Here’s to a new year filled with innovation, collaboration, and meaningful impact.
BioIntelliSense, Inc
Medical Device
Denver, Colorado 8,358 followers
A New Era of Continuous Health Monitoring and Clinical Intelligence
About us
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical-grade remote care from in-hospital to home. Learn how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services or visit our website at BioIntelliSense.com.
- Website
-
http://biointellisense.com
External link for BioIntelliSense, Inc
- Industry
- Medical Device
- Company size
- 51-200 employees
- Headquarters
- Denver, Colorado
- Type
- Privately Held
Locations
-
Primary
Get directions
Denver, Colorado , US
Employees at BioIntelliSense, Inc
Updates
-
“TeleNurses monitor the patient BioButtons, which are placed on patients and designed to track vital signs such as respiration and heart rate continuously. This facilitates the early detection of potential acute events and helps prevent issues before they arise, so we can effectively communicate our findings with the patient’s care team.” -Pauline Avila, Virtual Nurse at Houston Methodist We love hearing stories from nurses about how the BioButton® wearable device is helping them focus their time and attention where it matters most: providing excellent and compassionate care for their patients. Thank you, Pauline, for sharing your experience! Read more of Pauline and her nursing colleague’s experiences of implementing innovative technologies to improve workflow and enhance patient care here: https://lnkd.in/gTAjEJwu #continuousmonitoring #healthtech #RPM
-
New peer-reviewed research in the Journal of Clinical Medicine (JCM) MDPI underscores the transformational power of the BioIntelliSense medical-grade BioButton® wearable device and clinical intelligence solution for continuous patient monitoring at scale. One of the largest observational studies of nearly 12,000 patients for continuous vital sign monitoring with a medical-grade wearable device in medical-surgical units of the hospital highlights the transformative potential of medical-grade wearable monitoring technology and algorithmic-based analytics to enhance patient care. The results demonstrated a reduction in patient length of stay, low alert notification rates reducing alert fatigue, and early clinical intervention when patients experienced deterioration events. Results show that continuous patient monitoring with the FDA-cleared BioButton device enabled early detection of patient deterioration, on average 14.8 hours before the onset of symptomatic changes allowing for earlier clinical interventions. A reduction in a patient’s length of stay was also demonstrated with a decreased trend that has the potential to deliver economic benefits for hospitals and improved patient satisfaction for patients. Explore key takeaways from the observational study and how the comprehensive BioIntelliSense portfolio of continuous patient monitoring solutions allow for better, safer care from in-hospital to home.
-
🗓 Mark your calendars: BioIntelliSense founder and CEO, James Mault, MD, FACS, will be speaking at the upcoming American Heart Association (AHA) Scientific Sessions in Philadelphia in the #AHA24 Health Innovation Pavilion. Dr. Mault will join fellow healthcare innovation leaders Nino Isakadze, (Johns Hopkins Hospital), David Albert, (AliveCor), Mintu Turakhia MD MS, (iRhythm Technologies, Inc.) and Seth Shay Martin (moderator) (Johns Hopkins Hospital) to explore how AI is transforming healthcare from diagnostics and drug discovery to personalized medicine and virtual care. “AI Everywhere: Transforming Healthcare from Diagnostics to Virtual Care” 📍 Saturday, Nov. 16, 3:55 pm - 4:30 pm We hope to see you there! #AIinHealthcare #HealthTech #ContinuousMonitoring
-
-
This week, BioIntelliSense Founder & CEO James Mault, MD, FACS, joined industry leaders including Lisa Gulker (Oracle), Esteban Rubens (Oracle) and Mitesh Patel (Ascension) at the Oracle Health Summit for a panel discussion on the “Future of Wearables.” This global forum brings together innovators and experts shaping healthcare’s next frontier and developing new solutions for some of the industry’s biggest challenges. Dr. Mault spoke about the transformative impact of medical-grade wearables like the BioButton® for shifting from traditional, episodic care to continuous, intelligent monitoring at scale and enabling early detection of patient deterioration, proactive clinical interventions, and optimized workforce efficiency. #OracleHealthSummit #FutureOfWearables #DigitalHealth #ContinuousCare #HealthcareInnovation
-
-
In an era when health systems are facing intense budgetary and staffing pressures, hospitals need reliable, cost-effective solutions that can be integrated seamlessly to enhance clinical workflows while improving patient outcomes. The new FDA-cleared BioButton® Multi-Patient Wearable and BioDashboard System™ addresses these challenges head-on, delivering medical-grade continuous monitoring across medical surgical units, specialty care areas, emergency departments and in delivering hospital level care at home. Learn more: BioIntelliSense.com #ContinuousMonitoring #HealthCareInnovation
-
-
Dr. Geeta Nayyar, MD, MBA’s reflection on meeting BioIntelliSense founder and CEO James Mault, MD, FACS during her residency underscores how pivotal moments shape careers. It’s a privilege to see Dr. Mault's dedication inspire others as we work to advance healthcare innovation together. Thank you for sharing this inspiring memory, Dr. Nayyar!
Humanizing innovation for better health and business outcomes | Chief medical officer | Technologist | WSJ bestselling author, “Dead Wrong” | RadiantGraph | Salesforce, AT&T alum | #AI #Speaker
When I was a 20-some-year-old resident at George Washington University, I headed to grand rounds one day totally unaware that Jim Mault was going to change my life forever. In theory, physicians pause their otherwise nonstop days during grand rounds to listen to a lecture. In reality, grand rounds can also be an exercise in quiet and kind multitasking — listening deeply while also devouring lunch, whispering necessities with other residents, and keeping a watchful eye on your pager. When Jim came on stage, I froze. I put down my half-sandwich, stopped answering pages, and tuned into him like his words were gospel. “Did they just say he’s a CT surgeon?” I thought to myself. “And he works for Microsoft?” It was the first time I’d heard of a doctor working in tech, never mind a highly specialized surgeon. It seemed ludicrous at the time — no one I knew was doing that. And yet, I’d had dreams of doing *exactly* that. But the medical establishment made me feel crazy for wanting it. How could I “throw away” a solid medical background to work in tech? To what end? For what purpose? Jim answered all of those questions. He was changing the face of healthcare like no one else had before. He understood patients, the system, the clinical teams. He didn’t just want better, he demanded better. That day, I walked out of grand rounds and decided: “If that doc can do it, so can I!” Now Jim and I both sit on the board of the American Telemedicine Association, which feels surreal. I told him recently about the impact he had on me that day. He said he was touched. And then shared that now I inspire him in his work! Full circle. We all have something to offer our industries and our communities. We may not think anyone notices, but they do. You never know who you may inspire to move us all forward. Thank you for inspiring me and so many others, Jim!
-
-
We are thrilled that Fierce Healthcare has selected the medical-grade BioButton® wearable device as a finalist in the 2024 #FierceInnovationAwards! Hospital systems nationwide are deploying the multiparameter BioButton device to shift from traditional labor-intensive patient monitoring to a continuous, personalized and scalable model of care. The BioButton is transforming how patients are monitored from in-hospital to at home. This honor is a testament to the hard work, ingenuity and dedication of the team at BioIntelliSense, our amazing health system partners, and the incredible nurses and clinicians on the front lines of patient care.
-
-
Today, we’re thrilled to announce FDA clearance for the new BioIntelliSense BioButton® Multi-Patient wearable and BioDashboard™ clinical intelligence system. These additions to our growing portfolio of medical-grade, continuous patient monitoring solutions will equip hospitals with industry-leading tools for scalable exception management and automated vital sign collection. Here’s how: ➡ Rechargeable & Reusable: The BioButton Multi-Patient wearable is rechargeable and reusable, including a multi-device charging station, to provide a more cost-effective, sustainable solution for continuous patient monitoring across general care units in the hospital, as well as for hospital-at-home care. ➡ Data-Driven Exception Management: The BioDashboard's personalized, automated trending notifications enable clinicians to monitor hundreds of patients simultaneously, shifting from episodic to continuous vital sign monitoring. ➡ Enhanced Patient Care: Continuous vital sign tracking enables early detection of meaningful physiological changes, allowing for timely clinical interventions and improved patient outcomes. ➡ Workforce Efficiency: By automating vital sign capture and reducing manual tasks, the BioButton system enhances staff efficiency, reducing alert fatigue and improving response times with actionable clinical insights. ➡ Interoperable & Secure: The system integrates seamlessly with third-party platforms and EMR systems, adhering to strict privacy and security standards to support scalable virtual care programs. Learn more in Yahoo Finance: https://lnkd.in/g-fJQNnt #ContinuousCare #PatientMonitoring #BioButton
-
-
“We’re going to look back on this decade as one of the most profound moments in human healthcare on par with the discovery of immunization and antibiotics–even the x-ray machine.” – BioIntelliSense Founder and CEO James Mault, MD, FACS Dr. Mault shared his insights into the impact of modern, medical-grade wearables to accelerate the future of healthcare with M42 Health’s Managing Director and Group Chief Executive Officer Hasan Jasem Al Nowais and Microsoft’s Global Chief Medical Officer & VP of Healthcare David Rhew, M.D., M.D in Abu Dhabi. Thank you to Amandeep Bhangu for convening the panel of health leaders ushering in a new era of care. The future of healthcare is here, and it fits in the palm of your hand.